✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Rubicon Research Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Rubicon Research is 0

Growth Table

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Balance Sheet

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Cash Flow

  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Rubicon Research Ltd.
  • Sun Pharma Inds.
  • Aurobindo Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Rubicon Research Ltd. Financials

Rubicon Research balance sheet is weak and might have solvency issues

The net debt of Rubicon Research is decreasing.
Latest net debt of Rubicon Research is ₹161 Crs as of Mar-25.
This is less than Mar-24 when it was ₹284 Crs.

Yes, profit is increasing.
The profit of Rubicon Research is ₹134 Crs for Mar 2025, ₹91.01 Crs for Mar 2024 and -₹16.89 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rubicon Research latest dividend payout ratio is 0.02% and 3yr average dividend payout ratio is 0.03%

Companies resources are allocated to majorly unproductive assets like Inventory

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech